Correlation Between PDS Biotechnology and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Design Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Design Therapeutics.
Diversification Opportunities for PDS Biotechnology and Design Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PDS and Design is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Design Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Design Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Design Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.15 times less risky than Design Therapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The Design Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 541.00 in Design Therapeutics on August 30, 2024 and sell it today you would earn a total of 56.00 from holding Design Therapeutics or generate 10.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Design Therapeutics
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Design Therapeutics |
PDS Biotechnology and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Design Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| PDS Biotechnology vs. Ikena Oncology | PDS Biotechnology vs. Eliem Therapeutics | PDS Biotechnology vs. HCW Biologics | PDS Biotechnology vs. RenovoRx |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |